These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 5865817)
41. [Therapeutic use of a dried protein mixture in peptic ulcer]. Kolomoets MIu Vrach Delo; 1983 Nov; (11):55-7. PubMed ID: 6659459 [No Abstract] [Full Text] [Related]
42. [Treatment of peptic ulcer using a stable vegetable extract ("U" factor) by parenteral and oral route]. Lobosque P Rev Bras Med; 1968 Mar; 25(3):208-12. PubMed ID: 5740563 [No Abstract] [Full Text] [Related]
43. [Analysis of the value of the product geranyl farnesyl acetate (Gefarnate) in the treatment of peptic ulcer]. Nery AL; Nascif R Hospital (Rio J); 1966 Apr; 69(4):669-89. PubMed ID: 5295886 [No Abstract] [Full Text] [Related]
44. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)]. García Alvarez M; Ramírez Armengol JA Rev Clin Esp; 1972 Aug; 126(4):353-6. PubMed ID: 4638610 [No Abstract] [Full Text] [Related]
45. A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: A randomized, prospective, controlled study. Theilla M; Singer P; Cohen J; Dekeyser F Clin Nutr; 2007 Dec; 26(6):752-7. PubMed ID: 17933438 [TBL] [Abstract][Full Text] [Related]
47. [Results and indications of a lyophilized embryonic extract in the treatment of gastroduodenal ulcers]. Albot G; Boisson J Actual Hepatogastroenterol (Paris); 1966; 2(2):63-XXXVI. PubMed ID: 6011429 [No Abstract] [Full Text] [Related]
48. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261 [TBL] [Abstract][Full Text] [Related]
49. High IgE serum levels and "peptic" ulcers: clinical and functional approach. De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969 [TBL] [Abstract][Full Text] [Related]
50. [Anti-ulcer factor U in therapy of peptic ulcer with vit-U-pept gastrointestinal tablets]. VARGHA G; SZABO S Munch Med Wochenschr; 1958 Dec; 100(49):1936-9. PubMed ID: 13622537 [No Abstract] [Full Text] [Related]
51. [Use of the heparin-like drug ulcermin in the treatment of ulcer disease]. Britov AN; Sidorskii AL; Bozhko NV; Chanturiia ZhA Sov Med; 1972 Nov; 35(11):97-101. PubMed ID: 4582135 [No Abstract] [Full Text] [Related]
52. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)]. Castelli CA; Locatelli L; Salvioni GF Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065 [No Abstract] [Full Text] [Related]
53. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
54. [Treatment of ulcer patients with group B vitamins]. Ternavskiĭ AV; Okishev AP; Galantseva AF; Dimitrienko LS; Shlykov IA Vrach Delo; 1966 Sep; 9():131-2. PubMed ID: 6001243 [No Abstract] [Full Text] [Related]
55. [Treatment of peptic ulcer in internal medicine practice. A multicenter comparative study with roxatidine and cimetidine]. Raedsch R; Daake H; Eisold H; Schreiber H; Gorbauch T; Kriech W Fortschr Med; 1993 Sep; 111(26):413-6. PubMed ID: 7901134 [No Abstract] [Full Text] [Related]
56. [Treatment of patients with perforated pyloroduodenal ulcers]. Uteshev NS; Guliaev AA; Iartsev PA; Zabavskaia OA Khirurgiia (Mosk); 2003; (12):48-51. PubMed ID: 14671605 [TBL] [Abstract][Full Text] [Related]
57. [The clinico-histochemical validation of the differential use of calcium antagonists in gastroduodenal ulcers]. Birg NA Ter Arkh; 1994; 66(2):48-51. PubMed ID: 8160145 [TBL] [Abstract][Full Text] [Related]
58. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A; Remacha B; Sáinz R; Hirschowitz BI Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760 [TBL] [Abstract][Full Text] [Related]
59. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Savides TJ; Pratha V Gastrointest Endosc; 2001 Jul; 54(1):130-2. PubMed ID: 11447983 [No Abstract] [Full Text] [Related]
60. [Experiences with a cimetidine depot preparation (Neutronorm retard) in the treatment of peptic ulcer]. Pesendorfer FX; Salocher C Wien Med Wochenschr; 1983; 133(4-5):123-4, 126. PubMed ID: 6344445 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]